PRIMOVIST
PRIMOVIST
Approved
DIN Number
02340666
Drug Class
Human
Market Date
Feb 4, 2010
Company
HC
Bayer Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02340666
AIG Number0152685001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08CA10 GADOXETIC ACID
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification36:89.00*
Health Canada Classification
ACTIVE INGREDIENTS (1)
GADOXETATE DISODIUMActive
Strength: 181.43 MG / ML
Monograph: GADOXETATE DISODIUM